2480 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Beijing Luzhu Biotechnology Co., Ltd. engages in the development, production, and sale of active pharmaceutical ingredients. It focuses on the research and development of vaccine and therapeutic bispecific antibody for human disease prevention, control, and treatment. Its products include recombinant vaccine, bispecific antibody and immunoreagent. The company was founded on November 9, 2001 and is headquartered in Beijing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
2480 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company